CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-11 | Viret Jean-Frederic Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +126,000 | 126,000 | ||
| 2019-01-11 | Anicetti Vincent R Chief Operating Officer | Grant or award | +16,997 | 23,699 | ||
| 2019-01-11 | Anicetti Vincent R Chief Operating Officer | Shares withheld for taxes | −6,404 | $12.37 | $79K | 17,295 |
| 2019-01-11 | Anicetti Vincent R Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +126,000 | 126,000 | ||
| 2019-01-11 | Vexler Vladimir Chief Scientific Officer | Grant or award | +15,562 | 23,390 | ||
| 2019-01-11 | Vexler Vladimir Chief Scientific Officer | Shares withheld for taxes | −5,916 | $12.37 | $73K | 17,474 |
| 2019-01-11 | Vexler Vladimir Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +126,000 | 126,000 | ||
| 2018-11-16 | Vexler Vladimir Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2018-11-16 | Vexler Vladimir Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2018-11-16 | Vexler Vladimir Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2018-09-21 | Viret Jean-Frederic Chief Financial Officer | Option exercise | +740 | $13.50 | $10K | 4,519 |
| 2018-09-21 | Viret Jean-Frederic Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −740 | 111,741 | ||
| 2018-09-10 | FINCK BARBARA K Chief Medical Officer | Option exercise | +1,760 | $1.42 | $2K | 38,803 |
| 2018-09-10 | FINCK BARBARA K Chief Medical Officer | Sale | −1,760 | $18.58 | $33K | 37,043 |
| 2018-09-10 | FINCK BARBARA K Chief Medical Officer | Option exercise · Stock Option (right to buy) | −1,760 | 82,941 | ||
| 2018-08-29 | HEALY JAMES Director | Sale | −25,000 | $20.50 | $513K | 2,868,221 |
| 2018-08-13 | FINCK BARBARA K Chief Medical Officer | Option exercise | +1,760 | $1.42 | $2K | 38,803 |
| 2018-08-13 | FINCK BARBARA K Chief Medical Officer | Sale | −1,760 | $19.02 | $33K | 37,043 |
| 2018-08-13 | FINCK BARBARA K Chief Medical Officer | Option exercise · Stock Option (right to buy) | −1,760 | 84,701 | ||
| 2018-07-23 | Viret Jean-Frederic Chief Financial Officer | Sale | −9,291 | $18.56 | $172K | 3,779 |
Page 22 of 39 · 768 trades